
Myasthenia gravis market to exceed $16B by 2036 driven by rising diagnoses and new targeted biologics.
The myasthenia gravis market, valued at around $6 billion in 2025, is projected to grow at a 9.1% CAGR to surpass $16 billion by 2036. Growth is fueled by increasing diagnosed cases, especially among older populations, and a surge in innovative targe...


